Literature DB >> 12175506

Differential Pax6 promoter activity and transcript expression during forebrain development.

Tonya R Anderson1, Eva Hedlund, Ellen M Carpenter.   

Abstract

Three different Pax6 promoters -- P0, P1, and P alpha -- show differential activity in the developing eye and spinal cord. To examine promoter usage during forebrain development, we performed in situ hybridization and reverse transcription-polymerase chain reaction to detect transcripts initiated from each promoter. Promoter-specific transcripts are expressed within subdomains of total Pax6 expression, but differ from one another in their spatial localization and expression over time. Additionally, we identified a novel P0-initiated transcript and detected a developmentally regulated antisense transcript. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175506     DOI: 10.1016/s0925-4773(02)00051-5

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  12 in total

1.  Functional dissection of the paired domain of Pax6 reveals molecular mechanisms of coordinating neurogenesis and proliferation.

Authors:  Tessa Walcher; Qing Xie; Jian Sun; Martin Irmler; Johannes Beckers; Timucin Öztürk; Dierk Niessing; Anastassia Stoykova; Ales Cvekl; Jovica Ninkovic; Magdalena Götz
Journal:  Development       Date:  2013-03       Impact factor: 6.868

2.  Pax6 mediates ß-catenin signaling for self-renewal and neurogenesis by neocortical radial glial stem cells.

Authors:  Qini Gan; Albert Lee; Ryusuke Suzuki; Takashi Yamagami; Arjun Stokes; Bao Chau Nguyen; David Pleasure; Junjiang Wang; Hong-Wu Chen; Chengji J Zhou
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

3.  Disruption of reelin signaling alters mammary gland morphogenesis.

Authors:  Elvira Khialeeva; Timothy F Lane; Ellen M Carpenter
Journal:  Development       Date:  2011-02       Impact factor: 6.868

4.  The Tlx gene regulates the timing of neurogenesis in the cortex.

Authors:  Kristine Roy; Kathleen Kuznicki; Qiang Wu; Zhuoxin Sun; Dagmar Bock; Gunther Schutz; Nancy Vranich; A Paula Monaghan
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

5.  Brg1 directly regulates Olig2 transcription and is required for oligodendrocyte progenitor cell specification.

Authors:  Steven Matsumoto; Fatima Banine; Kerstin Feistel; Scott Foster; Rubing Xing; Jaime Struve; Larry S Sherman
Journal:  Dev Biol       Date:  2016-04-08       Impact factor: 3.582

6.  Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms.

Authors:  Jie Dong; Eijiro Jimi; Haihong Zhong; Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2008-04-11       Impact factor: 11.361

7.  Positive autoregulation of the transcription factor Pax6 in response to increased levels of either of its major isoforms, Pax6 or Pax6(5a), in cultured cells.

Authors:  Jeni Pinson; T Ian Simpson; John O Mason; David J Price
Journal:  BMC Dev Biol       Date:  2006-05-25       Impact factor: 1.978

8.  Long-range downstream enhancers are essential for Pax6 expression.

Authors:  Dirk A Kleinjan; Anne Seawright; Sebastien Mella; Catherine B Carr; David A Tyas; T Ian Simpson; John O Mason; David J Price; Veronica van Heyningen
Journal:  Dev Biol       Date:  2006-08-30       Impact factor: 3.582

9.  Dopamine Receptor Antagonists Enhance Proliferation and Neurogenesis of Midbrain Lmx1a-expressing Progenitors.

Authors:  Eva Hedlund; Laure Belnoue; Spyridon Theofilopoulos; Carmen Salto; Chris Bye; Clare Parish; Qiaolin Deng; Banafsheh Kadkhodaei; Johan Ericson; Ernest Arenas; Thomas Perlmann; András Simon
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

10.  Identification of different mechanisms leading to PAX6 down-regulation as potential events contributing to the onset of Hirschsprung disease.

Authors:  María Valle Enguix-Riego; Ana Torroglosa; Raquel María Fernández; María José Moya-Jiménez; Juan Carlos de Agustín; Guillermo Antiñolo; Salud Borrego
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.